 RedHill Biopharma Ltd NASDAQ: RDHL announced preliminary top-line data from Phase 23 study evaluating opaganib in hospitalized patients with severe COVID-19 pneumonia. Read Next: RedHill Biopharma To Test Upamostat In COVID-19 Patients In South Africa. 